non-small cell lung cancer Clinical Research Trials | TrialX

Loading...

Please select a valid location from the dropdown

Filter By

Clear all Advanced

Advanced Filters

Gender
Phase
Study Type
Sponsors
Accepts healthy volunteers
Online Trials
Age Group

Any (51)

Phase 0 (1)
Phase 1 (9)
Phase 1/2 (6)
Phase 2 (16)
Phase 3 (9)
Unknown (10)

Interventional (44)
Observational (6)

Hoffmann-La Roche (3)
BeiGene (2)
National Cancer Institute (NCI) (2)
Sanofi (2)
Second Affiliated Hospital, School of Medicine, Zhejiang University (2)
AIO-Studien-gGmbH (1)
AbbVie (1)
Ascentage Pharma Group Inc. (1)
Atreca, Inc. (1)
Beijing Pearl Biotechnology Limited Liability Company (1)
Blueprint Medicines Corporation (1)
Calithera Biosciences, Inc (1)
City of Hope Medical Center (1)
European Lung Cancer Working Party (1)
Fudan University (1)
Fundación GECP (1)
Genentech, Inc. (1)
Guangdong Association of Clinical Trials (1)
Guangzhou Institute of Respiratory Disease (1)
Gustave Roussy, Cancer Campus, Grand Paris (1)
Hospital Israelita Albert Einstein (1)
Icahn School of Medicine at Mount Sinai (1)
Istituto Clinico Humanitas (1)
JS InnoPharm, LLC (1)
Karyopharm Therapeutics Inc (1)
Merck Sharp & Dohme Corp. (1)
Mersana Therapeutics (1)
National Hospital Organization Nagoya Medical Center (1)
Oslo University Hospital (1)
Persephone Biosciences (1)
Scott R. Plotkin, MD, PhD (1)
Seattle Genetics, Inc. (1)
ShangHai HaiHe Pharmaceutical (1)
Shanghai JMT-Bio Inc. (1)
Shanghai Pulmonary Hospital, Shanghai, China (1)
Spectrum Pharmaceuticals, Inc (1)
Sun Yat-sen University (1)
Swiss Group for Clinical Cancer Research (1)
The Netherlands Cancer Institute (1)
The University of Hong Kong (1)
Universitaire Ziekenhuizen Leuven (1)
Wake Forest University Health Sciences (1)
Xuanwu Hospital, Beijing (1)
Yuhan Corporation (1)

No (51)

No (51)

Adult (18+) (51)
Pediatric (Under 18) (3)

I am/have/had

I am/have/hadnon-small cell lung cancer

I am/have/hadlung cancer

I am/have/hadsmall cell lung cancer

I am/have/hadmeasurable disease

I am/have/hadcancer

I am/have/hadstage iv non-small cell lung cancer

I am/have/hadmetastasis

I am/have/hadalopecia

I am/have/hadsolid tumour

I am/have/hadgilbert's syndrome

I am/have/hadbrain metastases

I am/have/hadneutrophil count

I am/have/hadbrain metastasis

I am/have/hadcancer chemotherapy

I am/have/hadchemoradiotherapy

I am/have/hadsquamous non-small cell lung cancer

I am/have/hadhair thinning

I am/have/hadplatelet count

I am/have/hadstereotactic body radiation therapy

I am/have/hadBRAF

added new label for I am/have/had

more

I am looking for

I am looking forpemetrexed

I am looking forcarboplatin

I am looking forgefitinib

I am looking forcisplatin

I am looking forepidermal growth factor

I am looking forpaclitaxel

I am looking fordocetaxel

I am looking fortyrosine

I am looking forgrowth factor

I am looking forpembrolizumab

I am looking forgemcitabine

I am looking forplatinum doublet

I am looking foradjuvant

I am looking forplatinum-based chemotherapy

I am looking forosimertinib

I am looking formelanoma

I am looking forkras

I am looking fornivolumab

I am looking formonoclonal antibodies

I am looking foratezolizumab

added new label for I am looking for

more

Advanced Filters

Loading...

Found 51 clinical trials

For Seniors
For adults
Recruiting in 100s
Observational Study
all
Family Medicine
Recruiting

The Real World Study of Neoadjuvant Immunotherapy in Early Stage NSCLC in China

Here we conducted this real world study to see whether neoadjuvant immunotherapy would bring MPR and survival benefits in NSCLC, for example, single agent immunotherapy or immunotherapy combination with chemotherapy. Furthermore biomarker analysis would be also performed to achieve personalized neoadjuvant immunotherapy.

non-small cell lung cancer

pneumonectomy

cancer

lung cancer

small cell lung cancer

0 views
19 Feb, 2024

1
2
3
4
5
6

Congrats! You have your own personal workspace now.

Learn more

© Copyright TrialX 2024 All rights reserved.